Wajeeh Irfan, MD
Vascular Surgery · Baton Rouge, LANPI 1689930356
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,887 of the $6,743 with a category attached, or 72.5%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.0%. Reporting peaked in 2023 at $2,331 and has fallen 84.7% since, to $358 in 2025.
Across 100 payments — averaging $67.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Endologix LLC$1K
- W. L. Gore & Associates, Inc.$1K
- Inari Medical, Inc.$686
- Terumo Medical Corporation$327
- Shockwave Medical, Inc$306
- plus $1K from 19 others
What the payments were for
- Consulting fees$1,14517%
- Speaking & faculty fees$451%
- Travel & lodging$66710%
- Food & beverage$4,88772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 11 | $1,414 |
| Endologix LLC | 5 | $1,337 |
| W. L. Gore & Associates, Inc. | 10 | $1,261 |
| Inari Medical, Inc. | 9 | $686 |
| Terumo Medical Corporation | 4 | $327 |
| Shockwave Medical, Inc | 8 | $306 |
| Bard Peripheral Vascular, Inc. | 7 | $288 |
| Boston Scientific | 9 | $217 |
| Avinger Inc. | 2 | $169 |
| Fresenius USA Marketing, Inc. | 6 | $130 |
| Cardiovascular Systems Inc. | 2 | $120 |
| Smith+Nephew | 7 | $110 |
| Johnson & Johnson(2 entities) | 4 | $79 |
| BD | 1 | $45 |
| Tactile Systems Technology Inc | 2 | $45 |
| AstraZeneca | 2 | $31 |
| Lemaitre Vascular, Inc. | 2 | $29 |
| Qapel Medical Inc | 1 | $26 |
| Kerecis Limited | 2 | $23 |
| Sanara Medtech Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $17 |
| Trisalus Life Sciences, Inc. | 1 | $16 |
| EKOS Corporation | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Thoracic Endoprosthesis$787
- AMPLATZ GOOSE NECK$672
- MO.MA ULTRA$473
- AFX$445
- FLOWTRIEVER CATHETER, S$401
- Alto Abdominal Stent Graft System$310
- Ovation$291
- AFX2$291
- ENDOCROSS Device$290
- Torus Stent Graft System$290
- CT THROMBECTOMY SYSTEM KIT$157
- GORE TAG Conformable Thoracic Endoprosthesis$142
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$142
- Endurant$134
- Azur CX Detachable$128
- PANTHERIS$119
- GLIDESHEATH SLENDER$113
- ANGIO-SEAL$113
- METACROSS OTW$113
- R2P MISAGO$113
How this compares
$6,743 in reported general payments places this provider in the 55th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $27,469 |
| XareltoRivaroxaban | 22 | $11,110 |
| ClopidogrelClopidogrel Bisulfate | 83 | $789 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $222 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $79 | $11,11022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 65 vascular surgery providers in Louisiana.
Other vascular surgery in Baton Rouge
- Michael Conners IiiBaton Rouge$70K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- London GuidryBaton Rouge$25K
- Paul DavisBaton Rouge$18K
- Gulrez MahmoodBaton Rouge$9K
- Matthew AbateBaton Rouge$9K
- Taylor GwinBaton Rouge$7K
- Madeline DillsBaton Rouge$5K
- James McNeilBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.